Page 1013 - Williams Hematology ( PDFDrive )

988 Part VII: Neutrophils, Eosinophils, Basophils, and Mast Cells CHAPTER 64: Classification and Clinical Manifestations of Neutrophil Disorders 989

103. Athens JW, Haab OP, Raab SO, et al: Leukokinetic studies: IV. The total blood, circu- 138. Gombart AF, Koeffler HP: Neutrophil specific granule deficiency and mutations in the
lating and marginal granulocyte pools and the granulocyte turnover rate in normal gene encoding transcription factor C/EBP (epsilon). Curr Opin Hematol 9:36, 2002.
subjects. J Clin Invest 40:989, 1961. 139. Hoffmann K, Dreger CK, Olins AL, et al: Mutations in the gene encoding the laminin
104. Kuijpers TW, Van Lier RA, Hamann D, et al: Leukocyte adhesion deficiency type 1 B receptor produce an altered nuclear morphology in granulocytes (Pelger-Hüet anom-
(LAD-1)/variant. A novel immunodeficiency syndrome characterized by dysfunctional aly). Nat Genet 31:410, 2002.
beta2 integrins. J Clin Invest 100:1725, 1997. 140. Worman HJ, Bonne G: “Laminopathies”: A wide spectrum of human diseases. Exp Cell
105. Etzioni A, Tonetti M: Leukocyte adhesion deficiency II—From A to almost Z. Immunol Res 313:2121, 2007.
Rev 178:138, 2000. 141. Brunning RD: Morphologic alterations in nucleated blood and marrow cells in genetic
106. MacGregor RR, Spagnulo PJ, Lentnek AL: Inhibition of granulocyte adherence by eth- disorders. Hum Pathol 1:99, 1970.
anol, prednisone, and aspirin, measured with an assay system. N Engl J Med 291:642, 142. Oski FA, Naiman JL, Allen DM, Diamond LK: Leukocytic inclusions—Döhle bod-
1974. ies-associated with platelet abnormality (the May-Hegglin anomaly): Report of a family
107. Boxer LA, Hedley-White ET, Stossel TP: Neutrophil actin dysfunction and abnormal and review of the literature. Blood 20:657, 1962.
neutrophil behavior. N Engl J Med 291:1043, 1974. 143. Pecci A, Panza E, Pujol-Moix N, et al: Position of nonmuscle myosin heavy chain IIA
108. Coates TD, Torkildson JC, Torres M, et al: An inherited defect of neutrophil motility (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease. Hum
and microfilamentous cytoskeleton associated with abnormalities in 47-Kd and 89-Kd Mutat 29:409, 2008.
proteins. Blood 78:1338, 1991. 144. Seri M, Pecci A, Di Bari F, et al: MYH9-related disease: May-Hegglin anomaly, Sebas-
109. Nunoi H, Yamazaki T, Kanegasaki S: Neutrophil cytoskeletal disease. Int J Hematol tian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but
74:119, 2001. represent a variable expression of a single illness. Medicine (Baltimore) 82:203, 2003.
110. Hill HR, Augustine NH, Jaffe HS: Human recombinant interferon gamma enhances 145. Westbroek W, Adams D, Huizing M, et al: Cellular defects in Chediak-Higashi syn-
neonatal PMN activation and movement increases free intracellular calcium. J Exp Med drome correlate with the molecular genotype and clinical phenotype. J Invest Dermatol
173:767, 1991. 127:2674, 2007.
111. Al-Hertani W, Yan SR, Byers DM, Bortolussi R: Human newborn polymorphonuclear 146. Lazarchick J, McRae B: Chediak-Higashi syndrome. Blood 105:4162, 2005.
neutrophils exhibit decreased levels of MyD88 and attenuated p38 phosphorylation in 147. Schmid-Schönbein GN: Leukocyte kinetics in the microcirculation. Biorheology
response to lipopolysaccharide. Clin Invest Med 30:E44, 2007. 24:139, 1987.
112. Klempner MS, Noring R, Meir JW, Atkins MB: An acquired chemo-tactic defect in neu- 148. Smedly LA, Tonnesen MG, Sandhaus RA, et al: Neutrophil-mediated injury to endo-
trophils from patients receiving interleukin-2 immunotherapy. N Engl J Med 322:959, thelial cells: Enhancement by endotoxin and essential role of neutrophil elastase. J Clin
1990. Invest 77:1233, 1986.
113. Kannengiesser C, Gérard B, El Benna J, et al: Molecular epidemiology of chronic gran- 149. Weiss SJ: Tissue destruction by neutrophils. N Engl J Med 320:365, 1989.
ulomatous disease in a series of 80 kindreds: Identification of 31 novel mutations. Hum 150. Swank DW, Moore SB: Roles of the neutrophil and other mediators in adult respiratory
Mutat 29:E132, 2008. distress syndrome. Mayo Clin Proc 64:1118, 1989.
114. Stasia MJ, Li XJ: Genetics and immunopathology of chronic granulomatous disease. 151. MacNee W, Wiggs B, Balzberg AS, Hogg JC: The effect of cigarette smoking on neu-
Semin Immunopathol 30:209, 2008. trophil kinetics in human lungs. N Engl J Med 321:924, 1989.
115. Gu Y, Williams DA: RAC2 GTPase deficiency and myeloid cell dysfunction in human 152. Martin TR, Pistorese BP, Hudson LD, Maunder RJ: The function of lung and blood
and mouse. J Pediatr Hematol Oncol 24:791, 2002. neutrophils in patients with the adult respiratory distress syndrome. Implication for the
116. Williams DA, Tao W, Yang F, et al: Dominant negative mutation of the hematopoi- pathogenesis of lung infections. Am Rev Respir Dis 144:254, 1991.
etic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodefi- 153. Godek JE: Adverse effects of neutrophils on the lung. Am J Med 92(Suppl 6A):27S, 1992.
ciency. Blood 96:1646, 2000. 154. Palmgren MS, deShazo RO, Cater RM, et al: Mechanisms of neutrophil damage to
117. Nauseef WM. Diagnostic assays for myeloperoxidase deficiency. Methods Mol Biol human alveolar extracellular matrix: The role of serine and metalloproteases. J Allergy
412:525, 2007. Clin Immunol 89:905, 1992.
118. Goedken M, McCormick S, Leidal KG, et al: Impact of two novel mutations on the 155. Weiss ST, Segal MR, Sparrow D, Wager C: Relation of FEV1 and peripheral blood leu-
structure and function of human myeloperoxidase. J Biol Chem 282:27994, 2007. kocyte count to total mortality. Am J Epidemiol 142:493, 1995.
119. Minegishi Y, Karasuyama H: Hyperimmunoglobulin E syndrome and tyrosine kinase 2 156. Fung YL, Goodison KA, Wong JK, Minchinton RM: Investigating transfusion-related
deficiency. Curr Opin Allergy Clin Immunol 7:506, 2007. acute lung injury (TRALI). Intern Med J 33:286, 2003.
120. Holland SM, DeLeo FR, Elloumi HZ, et al: STAT3 mutations in the hyper-IgE syn- 157. Segel GB, Halterman MW, Lichtman MA. The paradox of the neutrophil’s role in tissue
drome. N Engl J Med 357:1608, 2007. injury. J Leukoc Biol 89:359, 2011.
121. Cooper MR, DeChatelet LR, McCall CE, et al: Complete deficiency of leukocyte glu- 158. Boventre JV, Colvin RB: Adhesion molecules in renal disease. Curr Opin Nephrol
cose-6-phosphate dehydrogenase with defective bactericidal activity. J Clin Invest Hypertens 5:254, 1996.
51:769, 1972. 159. Kitching AR, Holdsworth SR, Hickey MJ: Targeting leukocytes in immune glomerular
122. Vives Corrons JL, Feliu E, Pujades MA, et al: Severe-glucose-6-phosphate dehydroge- diseases. Curr Med Chem 15:448, 2008.
nase (G6PD) deficiency associated with chronic hemolytic anemia, granulocyte dys- 160. Chibber R, Ben-Mahmud BM, Chibber S, Kohner EM: Leukocytes in diabetic retinop-
function, and increased susceptibility to infections: Description of a new molecular athy. Curr Diabetes Rev 3:3, 2007.
variant (G6PD Barcelona). Blood 59:428, 1982. 161. Fadlon E, Vordermeier S, Pearson TC, et al: Blood polymorphonuclear leukocytes from
123. Arturson G: Neutrophil granulocyte functions in severely burned patients. Burns Incl the majority of sickle cell patients in the crisis phase of the disease show adhesion to
Therm Inj 11:309, 1985. vascular endothelium and increased expression of CD64. Blood 91:266, 1998.
124. Ahmed S el-D, el-Shahat AS, Saad SO: Assessment of certain neutrophil receptors, 162. Schaub RG, Yamashita A, Simmons CA, et al: Leukocyte-mediated large vein injury
opsonophagocytosis and soluble intercellular adhesion molecule-1 (ICAM-1) follow- and thrombosis: Pharmacologic intervention with lipoxygenase inhibitors, in Leuko-
ing thermal injury. Burns 25:395, 1999. cyte Emigration and Its Sequelae, edited by Morat HZ, p 62. Karger, Basel, 1987.
125. Lesma E, Riva E, Giovannini M, et al: Amelioration of neutrophil membrane function 163. Ranjadayalan K, Umachandran V, Daviews SW, et al: Thrombolytic treatment in acute
underlies granulocyte-colony stimulating factor action in glycogen storage disease 1b. myocardial infarction: Neutrophil activation, peripheral leucocyte responses, and myo-
Int J Immunopathol Pharmacol 18:297, 2005. cardial injury. Br Heart J 66:10, 1991.
126. Kim SY, Jun HS, Mead PA, et al: Neutrophil stress and apoptosis underlie myeloid dys- 164. Welbourn CRB, Goldman G, Paterson IS, et al: Pathophysiology of ischaemia reperfu-
function in glycogen storage disease type Ib. Blood 111:5704, 2008. sion injury: Central role of the neutrophil. Br J Surg 78:651, 1991.
127. Tamura DY, Moore EE, Patrick DA, et al: Clinically relevant concentrations of ethanol 165. Kassirer M, Zeltser D, Gluzman B, et al: The appearance of L-selectin (low) polymor-
attenuate primed neutrophil bacteriocidal activity. J Trauma 44:320, 1998. phonuclear leukocytes in the circulating pool of peripheral blood during myocardial
128. Breitmeier D, Becker N, Weilbach C, et al: Ethanol-induced malfunction of neutrophils infarction correlates with neutrophilia and the size of the infarct. Clin Cardiol 22:721,
respiratory burst on patients suffering from alcohol dependence. Alcohol Clin Exp Res 1999.
32:1708, 2008. 166. Takahashi T, Hiasa Y, Ohara Y, et al: Relationship of admission neutrophil count to
129. Porter CJ, Burden RP, Morgan AG, et al: Impaired bacterial killing and hydrogen perox- microvascular injury, left ventricular dilation, and long-term outcome in patients
ide production by polymorphonuclear neutrophils in end-stage renal failure. Nephron treated with primary angioplasty for acute myocardial infarction. Circ J 72:867, 2008.
77:479, 1997. 167. Takahashi T, Hiasa Y, Ohara Y, et al: Relation between neutrophil counts on admission,
130. Hopps E, Camera A, Caimi G: [Polimorphonuclear leukocytes and diabetes mellitus] microvascular injury, and left ventricular functional recovery in patients with an ante-
[in Italian]. Minerva Med 99:197, 2008. rior wall first acute myocardial infarction treated with primary coronary angioplasty.
131. Davidson WM, Milner RDG, Lawlor SD: Giant neutrophil leukocytes: An inherited Am J Cardiol 100:35, 2007.
anomaly. Br J Haematol 6:339, 1960. 168. Kyne L, Hausdorff JM, Knight E, et al: Neutrophilia and congestive heart failure after
135. Undritz VE: Eine neue Sippe mit Erblich—Konstitutioneller Hochsegmentierung der acute myocardial infarction. Am Heart J 139:32, 2000.
Neutrophilenkerne. Schweiz Med Wochenschr 94:1365, 1964. 169. Buck BH, Liebeskind DS, Saver JL, et al: Early neutrophilia is associated with volume of
136. Uzel G, Holland SM: White blood cell defects: Molecular discoveries and clinical man- ischemic tissue in acute stroke. Stroke 39:355, 2008.
agement. Curr Allergy Asthma Rep 2:385, 2002. 170. Trush MA, Seed JL, Kensler TW: Oxidant-dependent metabolic activation of polycyclic
137. Lekstrom-Himes JA, Dorman SE, Kopar P, et al: Neutrophil-specific granule deficiency aromatic hydrocarbons by phorbol ester-stimulated human polymorphonuclear leuko-
results from a novel mutation with loss of function of the transcription factor CCAAT/ cytes: Possible link between inflammation and cancer. Proc Natl Acad Sci U S A 82:5194,
enhancer binding protein. J Exp Med 189:1847, 1999. 1985.

Kaushansky_chapter 64_p0983-0990.indd 988 9/17/15 3:28 PM